H01H35/146

METHOD AND SYSTEM FOR PROVIDING A PREDETERMINED PYROTECHNIC ENERGY OUTPUT
20220351927 · 2022-11-03 ·

Summary

The present invention relates to a process for providing a predetermined pyrotechnic energy output, comprising a pyrotechnic material that pyrotechnically converts at a material-specific conversion temperature, and communicating heat to the pyrotechnic material to convert the pyrotechnic material at an ambient temperature of the pyrotechnic material that is less than the conversion temperature.

IMAGE ACQUISITION METHODS FOR SIMULTANEOUSLY DETECTING GENETIC REARRANGEMENT AND NUCLEAR MORPHOLOGY

In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.

Image acquisition methods for simultaneously detecting genetic rearrangement and nuclear morphology

In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.

Sensing and responding to an explosion local to a vehicle

A vehicle and a sensor for use in the vehicle is disclosed. The vehicle includes: a sensor array configured to detect an explosion by sensing, at different heights within a base of the vehicle, mechanical deformation of the base of the vehicle caused by the explosion; and control circuitry configured to respond to detection of the explosion by causing a groundwards force to be applied to the vehicle that depends upon inputs, characterizing the explosion, provided by the sensor array. The sensor includes: at least one support; a first frangible electrical connection, for conveying an electrical signal, held by the at least one support at a first height; and a second frangible electrical connection, for conveying an electrical signal, held by the at least one support at a second height different from the first height.

SPECTRAL IMAGING FOR MEASUREMENT OF NUCLEAR PATHOLOGY FEATURES IN CANCER CELLS PREPARED FOR IN SITU ANALYSIS

In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.

Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis

In general, the presently disclosed technology relates to identification of cancer subtypes. More specifically, the technology relates to methods for determining molecular drivers of cancer and/or progression using a multivariate image data and statistical analysis of in-situ molecular markers and morphological characteristics in the same cells of a biological sample suspected of b cancer. This analysis takes place after a single acquisition that obtains the molecular and anatomic morphology data in parallel. The analysis compares specific morphological and molecular markers to known samples exhibiting particular genetic drivers of the cancer. This method provides statistical information that allows for an increased confidence in the identification of specific molecular drivers of the cancer.